PharmaCorp Rx (TSXV:PCRX) ROE % Adjusted to Book Value : -5.52% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is PharmaCorp Rx ROE % Adjusted to Book Value?

PharmaCorp Rx's ROE % for the quarter that ended in Sep. 2024 was -14.95%. PharmaCorp Rx's PB Ratio for the quarter that ended in Sep. 2024 was 2.71. PharmaCorp Rx's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -5.52%.

PharmaCorp Rx ROE % Adjusted to Book Value Historical Data

The historical data trend for PharmaCorp Rx's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCorp Rx ROE % Adjusted to Book Value Chart

PharmaCorp Rx Annual Data

Trend

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-3.18

-5.02

PharmaCorp Rx Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-4.69	-9.67	-9.02	-21.38	-5.52

Competitive Comparison of PharmaCorp Rx's ROE % Adjusted to Book Value

For the Shell Companies subindustry, PharmaCorp Rx's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaCorp Rx's ROE % Adjusted to Book Value Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, PharmaCorp Rx's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PharmaCorp Rx's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

PharmaCorp Rx ROE % Adjusted to Book Value Calculation

PharmaCorp Rx's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-18.83%	/	3.75
	=	-5.02%

PharmaCorp Rx's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-14.95%	/	2.71
	=	-5.52%

PharmaCorp Rx ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCorp Rx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1

Website

PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.